Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ICR holds first networking event for scientists and commercial partners
The ICR’s Enterprise Unit has hosted our first ever event for our scientists to meet with possible future partners from the commercial sector.
ICR celebrates a new generation of cancer researchers
The ICR award ceremony took place yesterday, to celebrate the hard work and achievements of our 2018 student graduates – and future generation of cancer researchers.
Broadcaster Victoria Derbyshire and former Cancer Research UK CEO Sir Harpal Kumar awarded honorary doctorates
The ICR has invited three individuals to receive Honorary Degrees to recognise and celebrate their dedication and outstanding achievements in cancer research and awareness.
ICR features in prestigious report on university-business collaboration
A new strategic partnership between The ICR, the pharma company Merck and Cancer Research UK features in a new report on effective collaborations between academics and industry partners.
New ‘triple therapy’ could boost treatment and prevent relapse of advanced breast cancer
Treating advanced breast cancer with three drugs instead of one could boost the effectiveness of treatment and stop tumours developing resistance, a new study reports.
Teamwork between cells fuels aggressive childhood brain tumour
Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumour work together to infiltrate the brain, and this finding could ultimately lead to much needed new treatments, according to a new study.
Immunotherapy drug for skin disease could boost hormone treatment for prostate cancer
A new form of immunotherapy reactivates the response to hormone treatment in advanced prostate cancer, a study in mice and human prostate cancer cells has found.
ICR and partners take centre stage at major international conferences
Clinical trials of promising cancer treatments discovered or developed at the ICR were among the highlights at this year’s American Society of Clinical Oncology (ASCO) meeting, the biggest international clinical cancer research gathering of the year.
Professor Mel Greaves awarded prestigious Society of Memorial Sloan Kettering Prize for contributions to childhood cancer
The ICR’s Professor Mel Greaves has been awarded a prestigious prize from the Memorial Sloan Kettering Cancer Center in New York for his ground-breaking research and expertise in childhood leukaemia.
Higher BMI is associated with a lower risk of breast cancer before the menopause
Having a higher body mass index (BMI) at a younger age is associated with a decreased risk of developing breast cancer before the menopause, major new research funded by Breast Cancer Now and other collaborators has found.
ICR ranked among the world’s best research institutions for industry collaboration
The ICR has ranked in the top 30 higher education institutions in the world for research in an independent evaluation funded by the European Commission.
Gene testing could identify men with prostate cancer who may benefit from immunotherapy
Scientists have identified a pattern of genetic changes that could pick out men with advanced prostate cancer who are likely to benefit from immunotherapy.